Emu Park in central Queensland
Source; Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Shares in Zenith Minerals Ltd (ASX:ZNC) have risen more than 13% as the company told investors it had sold its remaining 49% interest in the Develin Creek copper-zinc project in central Queensland to QMines Ltd (ASX:QML).

The sale means that Zenith now holds a fairly large stake in QMines – with the sale delivering $687,500 worth of shares in the latter company (or 10,261,194 shares), as well as $975,000 in cash (plus GST).

The two companies agreed to adjust the final consideration payable following a metallurgical test work program on the project, with the final payment forming the second part of a two-stage transaction reported earlier this month.

Zenith managing director Andrew Smith said he was pleased the transaction had been completed successfully.

“This transaction represents the culmination of a productive collaboration with QMines and underscores our ongoing commitment to delivering value to our shareholders,” he said.

“We are excited about the continued growth and development of the Develin Creek project under QMines’ stewardship.”

At 15:17 AEST, Zenith shares were trading at 4.9 cents – a rise of 13.95% since the market opened.

Join the discussion: See what HotCopper users are saying about Zenith and be part of the conversations that move the markets.


ZNC by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…